PER
Click for more information
4.00% 7.2¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-724

  1. sken
    43 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    16/10/21
    07:55
    Post #: 56844092
    I was thinking about this too. Perhaps Sarepta want EMA approval of the trial design before announcing (would be embarrassing to cap raise and have trial rejected)and anp need to show the ema how they intend to fund the trial to get the approval? so this would be a situation where the ema approval would be catalyst for the deal to happen. Just a theory
    ANP Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel
right-arrow Created with Sketch.
RHK Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit
right-arrow Created with Sketch.
IGO IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
right-arrow Created with Sketch.
NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
right-arrow Created with Sketch.
NEWS Nine staff strike as Paris Olympic coverage begins
right-arrow Created with Sketch.
MIN MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.2¢ 		Change
-0.003(4.00%) 		Mkt cap ! $65.81M
Open High Low Value Volume
7.3¢ 7.3¢ 7.2¢ $16.52K 226.7K

Buyers (Bids)

No. Vol. Price($)
2 123420 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8181 1
View Market Depth
Last trade - 10.49am 29/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.